Overview
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
Status:
Completed
Completed
Trial end date:
2007-03-01
2007-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hamamatsu UniversityTreatments:
Beclomethasone
Budesonide
Criteria
Inclusion Criteria:- Receive ICS for one year or more, with no change in dose within the previous 8 weeks
Exclusion Criteria:
- Two or more courses of oral corticosteroid in the previous 12 months
- Admission to hospital due to asthma in the previous 6 months
- Admission to the intensive care unit due to asthma at any time in the past
- Current cigarette smoker.